Global Implantable Ports Market
The Global Implantable Ports Market was valued at US$609.5 million in 2021 and it is expected to reach at US$1077.55 million in 2027 at a CAGR of 7.3 % during forecast period 2022-2027.
An implanted port consists of a tiny reservoir connected to a flexible, thin silicone tube. Usually, it is positioned in the arm or just below the chest skin. The other end of the tube, which is attached to the port, is placed into a significant vein just above the person's heart. Other names for implantable ports include chest ports, subcutaneous ports, and portacaths. Implantable ports are used during chemotherapy, blood transfusions, and the infusion of antibiotics and other drugs. Through ports, blood tests are also possible. These are incredibly useful for slowly injecting medication into a vein.
Market Drivers
There are several benefits to using implantable port devices for drug infusion. By eliminating the need for catheter or needle insertion, implantable port devices also lower the risk of infection. While undergoing infusion treatments, such as chemotherapy for cancer, implantable port devices urge patients to move around and exercise. The market for implantable ports will expand at a faster rate due to the high number of cancer patients and cancer treatment facilities. Additionally, over the anticipated timeframe, market value growth will be fuelled by an increase in health care spending as well as rising urbanisation.
Market Restraints
The negative effects of implantable port devices, such as clogged lines and blood clots in ports, are the key factors restraining the growth of the global market for implanted port devices. Factors will make it difficult for the market for implantable ports to expand. The market for implantable ports will suffer from the availability of substitute products. The market growth rate for implantable ports is therefore expected to be challenged by this reason.
Market Segmentation
The implantable ports market is segmented into product type, material type, application and end user. On the basis of product type it segmented into single lumen, duel lumen. On the basis of material type it segmented into polyurethane, polyethylene, silicone, others. On the basis of application it segmented into chemotherapy, blood transfusion, antibiotics, intravenous infusion of blood product, pain management, others. On the basis of end user it segmented into hospitals, clinics, ambulatory sugary center, dialysis centers, others.
Regional Analysis
The global implantable ports market segmented into five regions North America, Europe, Latin America, Asia Pacific, Middle East and Africa. In terms of market revenue and market share, North America currently holds a dominant position and will maintain it during the forecast period. The rising number of applications in the region is responsible for the market expansion in this area. In contrast, the Asia-Pacific area is anticipated to have profitable growth during the projected period as a result of rising investment on R&D in the region's emerging economies.
Key Players
Various key players are listed in this report such as A.M.I GmBH (Austria) GlaxoSmithKline plc.(U.K), Bausch Health Companies Inc., (Canada), Teligent (U.S.), Perrigo Company plc (U.S.), Allergan (Ireland), Biofrontera, AG (U.S.), Crown (U.S.), Akorn Operating Company LLC. (U.S.), Ingenus (U.S.).
Market Taxonomy
By Product Type
By Material Type
By Application
By End User
Key Question Addressed by the Report
Global Implantable Ports Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Implantable Ports Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Implantable Ports Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Squash Drink Market Share Analysis, By Product Type
5.3 Global Squash Drink Market Size and Forecast, By Product Type
5.3.1 Single Lumen
5.3.2 Duel Lumen
6 Global Implantable Ports Market, By Material Type
6.1 Y-o-Y Growth Comparison, By Material Type
6.2 Global Squash Drink Market Share Analysis, By Material Type
6.3 Global Squash Drink Market Size and Forecast, By Material Type
6.3.1 Polyurethane
6.3.2 Polyethylene
6.3.3 Silicone
6.3.4 Others
7 Global Implantable Ports Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Squash Drink Market Share Analysis, By Application
7.3.1 Chemotherapy
7.3.2 Blood Transfusion
7.3.3 Antibiotics
7.3.4 Intravenous Infusion of Blood Product
7.3.5 Pain Management
7.3.6 Others
8 Global Implantable Ports Market, By End User
8.1 Y-o-Y Growth Comparison, By End User
8.2 Global Squash Drink Market Share Analysis, By End User
8.3 Global Squash Drink Valve Market Size and Forecast, By End User
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Ambulatory Sugary Center
8.3.4 Dialysis Centers
9 Global Implantable Ports Market, By Region
9.1 Global Squash Drink Market Share Analysis, By Region
9.2 Global Squash Drink Market Share Analysis, By Region
10 North America Implantable Ports Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 North America Squash Drink Market Share Analysis, By Product Type
10.3 North America Squash Drink Market Size and Forecast, By Material Type
10.4 North America Squash Drink Market Size and Forecast, By Application
10.5 North America Squash Drink Market Size and Forecast, By End User
10.5 North America Squash Drink Market Size and Forecast, By Country
10.5.1 U.S
10.5.1 Canada
10.5.3 Mexico
11 Europe Implantable Ports Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Europe Squash Drink Market Share Analysis, By Product Type
11.3 Europe Squash Drink Market Size and Forecast, By Material Type
11.4 Europe Squash Drink Market Size and Forecast, By Application
11.5 Europe Squash Drink Market Size and Forecast, By End User
11.6 Europe Squash Drink Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4 Rest of Europe
12 Asia Pacific Implantable Ports Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Asia Pacific Squash Drink Market Size and Forecast, By Product Type
12.3 Asia Pacific Squash Drink Market Size and Forecast, By Material Type
12.4 Asia Pacific Squash Drink Market Size and Forecast, By Application
12.5 Asia Pacific Squash Drink Market Size and Forecast, By End User
12.6 Asia Pacific Squash Drink Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4. Rest of Asia Pacific
13 Latin America Implantable Ports Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Latin America Squash Drink Market Size and Forecast, By Product Type
13.3 Latin America Squash Drink Market Size and Forecast, By Material Type
13.4 Latin America Squash Drink Market Size and Forecast, By Application
13.5 Latin America Squash Drink Market Size and Forecast, By End User
13.6 Latin America Squash Drink Market Size and Forecast, Country
13.6.1 Brazil
13.6.2. Rest of Latin America
14 Middle East Implantable Ports Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Middle East Squash Drink Market Share Analysis, By Product Type
14.3 Middle East Squash Drink Market Size and Forecast, By Material Type
14.4 Middle East Squash Drink Market Size and Forecast, By Application
14.5 Middle East Squash Drink Market Size and Forecast, By End User
14.6 Middle East Squash Drink Market Size and Forecast, By Country
14.6.1. Saudi Arabia
14.6.2. UAE
14.6.3. Egypt
14.6.4. Kuwait
14.6.5. South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1. A.M.I GmBH (Austria)
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2. GlaxoSmithKline PLC .(U.K.)
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3. Teligent (U.S.)
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4. Perrigo Company PLC. (U.S.)
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5. Allergan (Ireland)
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6. Biofrontera, AG (U.S.)
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7. Crown (U.S.)
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8. Akorn Operating Company LLC. (U.S.)
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9. Ingenus (U.S.)
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10. Bausch Health Companies Inc. (Canada)
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies
